Nature CommunicationsNeurosciencePeer-reviewed journal article
Divergent impacts of C9orf72 repeat expansion on neurons and glia in ALS and FTD
Junhao LiiD, Manoj K. JaiswaliD, Jo-fan ChieniD, Alexey KozlenkoviD, Jinyoung JungiD, Ping Zhou, Mahammad Gardashli, Luc PregentiD, Erica Engelberg-CookiD, Dennis W. DicksoniD, Véronique BelziliD, Eran A. MukameliD, Stella M. DrachevaiD
Abstract
Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are strongly influenced by inherited genetic variation, but environmental and epigenetic factors also play key roles in the course of these diseases. A hexanucleotide repeat expansion in the C9orf72 (C9) gene is the most common genetic cause of ALS and FTD. To determine the cellular alterations associated with the C9 repeat expansion, we performed single nucleus transcriptomics (snRNA-seq) and epigenomics (snATAC-seq) in postmortem samples of motor and frontal cortices from C9-ALS and C9-FTD donors. We found pervasive alterations of gene expression across multiple cortical cell types in C9-ALS, with the largest number of affected genes in astrocytes and excitatory neurons. Astrocytes increased expression of markers of activation and pathways associated with structural remodeling. Excitatory neurons in upper and deep layers increased expression of genes related to proteostasis, metabolism, and protein expression, and decreased expression of genes related to neuronal function. Epigenetic analyses revealed concordant changes in chromatin accessibility, histone modifications, and gene expression in specific cell types. C9-FTD patients had a distinct pattern of changes, including loss of neurons in frontal cortex and altered expression of thousands of genes in astrocytes and oligodendrocyte-lineage cells. Overall, these findings demonstrate a context-dependent molecular disruption in C9-ALS and C9-FTD, resulting in distinct effects across cell types, brain regions, and disease phenotypes. One Sentence SummaryC9orf72-associated ALS and FTD showed a distinct pattern of transcriptome changes, with the largest number of affected genes in C9-ALS in astrocytes and excitatory neurons in upper and deep layers.
- organism: human
- assay: snRNA-seq
- assay: ATAC-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell type annotation
- approach: statistical model
- approach: experimental assay
- Citations
- 78
- FWCI
- 13.20
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types
Iris Broce, Daniel W. Sirkis, … Jennifer S. Yokoyama·Frontiers in NeurosciencePeer-reviewed·Feb 26, 2024
- Neuronal Activity-Dependent Gene Dysregulation in C9orf72 i3 Neuronal Models of ALS/FTD Pathogenesis
Layla Ghaffari, Emily M. Welebob, … Aaron R. Haeusler·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Aug 28, 2025
- Astrocyte dysfunction distinguishes monozygotic twin C9orf72 expansion carriers discordant for amyotrophic lateral sclerosis.
Allan Christian Shaw, Iris-Stefania Pasniceanu, … Pamela J. Shaw·bioRxiv·Jul 20, 2026
- pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients
Hsiao‐Lin V. Wang, Jian‐Feng Xiang, … Zachary T. McEachin·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 25, 2025
- Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1 transcription signature
Dunxin Shen, Alec J. Vincent, … Teresa Niccoli·Cell ReportsPeer-reviewed·Apr 1, 2025
- Single-nucleus transcriptome atlas of orbitofrontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms
Paul M. McKeever, Aiden M. Sababi, … Janice Robertson·Cell GenomicsPeer-reviewed·Sep 17, 2025